| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5 | 1.265 | 1.109 | 8.375 | 1.895 | 2.788 | 2.318 | 4.651 | 6.196 | 10.756 |
| Total Income - EUR | 1.142 | 1.265 | 25.252 | 22.200 | 10.597 | 12.405 | 18.027 | 15.312 | 11.535 | 23.869 |
| Total Expenses - EUR | 3.238 | 3.486 | 7.615 | 10.673 | 10.571 | 10.004 | 12.485 | 14.367 | 7.562 | 22.304 |
| Gross Profit/Loss - EUR | -2.096 | -2.221 | 17.637 | 11.527 | 25 | 2.401 | 5.542 | 944 | 3.973 | 1.565 |
| Net Profit/Loss - EUR | -2.096 | -2.259 | 17.605 | 11.427 | -32 | 2.320 | 5.472 | 895 | 3.218 | 1.268 |
| Employees | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Bio Sanddorn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.034 | 5.962 | 3.905 | 473 | 22.332 | 27.355 | 19.499 | 17.331 | 26.772 | 263.004 |
| Current Assets | 2.308 | 2.253 | 12.751 | 28.382 | 4.305 | 3.881 | 13.734 | 16.402 | 11.103 | 16.107 |
| Inventories | 1.152 | 1.140 | 1.226 | 1.204 | 1.180 | 1.221 | 0 | 0 | 964 | 1.021 |
| Receivables | 844 | 1.017 | 1.216 | 6.756 | 910 | 896 | 1.241 | 2.146 | 2.005 | 7.175 |
| Cash | 311 | 97 | 10.308 | 20.422 | 2.215 | 1.764 | 12.493 | 14.256 | 8.133 | 7.911 |
| Shareholders Funds | -2.373 | -4.608 | 15.997 | 27.137 | 26.579 | 28.395 | 33.183 | 34.187 | 37.301 | 38.360 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 27.695 | 27.781 | 27.696 | 27.542 |
| Debts | 12.715 | 12.824 | 659 | 1.719 | 57 | 2.841 | 50 | 246 | 574 | 240.751 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "128 - 128" | |||||||||
| CAEN Financial Year |
128
|
|||||||||
Comments - Bio Sanddorn Srl